RCAG
CVS icon

Rehmann Capital Advisory Group’s CVS Health CVS Stock Holding History

Rehmann Capital Advisory Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$524K Sell
7,290
-149
-2% -$11.5K 0.03% 390
2025
Q4 		$590K Sell
7,439
-3,073
-29% -$242K 0.03% 351
2025
Q3 		$784K Buy
10,512
+279
+3% +$19.1K 0.04% 279
2025
Q2 		$706K Sell
10,233
-10,194
-50% -$668K 0.04% 280
2025
Q1 		$1.38M Buy
20,427
+1,658
+9% +$99.2K 0.09% 169
2024
Q4 		$843K Sell
18,769
-188
-1% -$10.5K 0.05% 239
2024
Q3 		$1.2M Sell
18,957
-1,146
-6% -$66.9K 0.08% 186
2024
Q2 		$1.19M Sell
20,103
-3,283
-14% -$205K 0.09% 182
2024
Q1 		$1.87M Buy
23,386
+447
+2% +$34.1K 0.14% 123
2023
Q4 		$1.81M Buy
22,939
+1,208
+6% +$86K 0.15% 112
2023
Q3 		$1.52M Buy
21,731
+1,116
+5% +$79.1K 0.14% 119
2023
Q2 		$1.43M Buy
20,615
+1,649
+9% +$117K 0.13% 128
2023
Q1 		$1.41M Sell
18,966
-133
-0.7% -$11.2K 0.13% 130
2022
Q4 		$1.78M Sell
19,099
-371
-2% -$35.8K 0.18% 106
2022
Q3 		$1.86M Sell
19,470
-8
-0% -$792 0.21% 96
2022
Q2 		$1.8M Sell
19,478
-412
-2% -$40.2K 0.2% 100
2022
Q1 		$2.01M Sell
19,890
-758
-4% -$79.6K 0.19% 100
2021
Q4 		$2.13M Buy
20,648
+378
+2% +$34.9K 0.2% 90
2021
Q3 		$1.72M Sell
20,270
-390
-2% -$32.7K 0.16% 105
2021
Q2 		$1.73M Sell
20,660
-10,674
-34% -$874K 0.17% 99
2021
Q1 		$2.36M Buy
31,334
+561
+2% +$40.9K 0.24% 75
2020
Q4 		$2.1M Buy
30,773
+785
+3% +$51.1K 0.24% 78
2020
Q3 		$1.75M Buy
29,988
+259
+0.9% +$16.1K 0.22% 86
2020
Q2 		$1.93M Buy
29,729
+1,805
+6% +$114K 0.26% 74
2020
Q1 		$1.66M Buy
+27,924
New +$1.86M 0.27% 70
2019
Q3 		$1.77M Buy
28,009
+18,977
+210% +$1.12M 0.21% 53
2019
Q2 		$492K Buy
9,032
+579
+7% +$31.2K 0.06% 252
2019
Q1 		$456K Sell
8,453
-491
-5% -$30.3K 0.06% 239
2018
Q4 		$586K Sell
8,944
-2,655
-23% -$198K 0.09% 116
2018
Q3 		$913K Buy
11,599
+389
+3% +$27.8K 0.13% 138
2018
Q2 		$721K Sell
11,210
-579
-5% -$38.2K 0.1% 160
2018
Q1 		$733K Buy
11,789
+2,271
+24% +$163K 0.11% 148
2017
Q4 		$690K Sell
9,518
-1,394
-13% -$101K 0.12% 155
2017
Q3 		$887K Buy
10,912
+705
+7% +$55.8K 0.16% 118
2017
Q2 		$821K Buy
10,207
+798
+8% +$63K 0.16% 120
2017
Q1 		$739K Sell
9,409
-2,497
-21% -$199K 0.12% 144
2016
Q4 		$940K Sell
11,906
-1,953
-14% -$158K 0.17% 116
2016
Q3 		$1.23M Sell
13,859
-1,622
-10% -$153K 0.24% 85
2016
Q2 		$1.48M Sell
15,481
-592
-4% -$59K 0.28% 78
2016
Q1 		$1.67M Buy
16,073
+3,681
+30% +$358K 0.32% 65
2015
Q4 		$1.21M Buy
12,392
+421
+4% +$41.2K 0.25% 78
2015
Q3 		$1.16M Buy
11,971
+33
+0.3% +$3.47K 0.26% 80
2015
Q2 		$1.25M Buy
11,938
+312
+3% +$31.9K 0.29% 74
2015
Q1 		$1.2M Buy
11,626
+612
+6% +$61.9K 0.27% 75
2014
Q4 		$1.06M Sell
11,014
-1,100
-9% -$96.9K 0.24% 85
2014
Q3 		$964K Buy
12,114
+149
+1% +$11.7K 0.23% 86
2014
Q2 		$902K Buy
11,965
+426
+4% +$32.2K 0.22% 88
2014
Q1 		$864K Buy
11,539
+1,579
+16% +$112K 0.23% 81
2013
Q4 		$713K Sell
9,960
-1,110
-10% -$71.3K 0.22% 91
2013
Q3 		$628K Sell
11,070
-660
-6% -$39.3K 0.2% 95
2013
Q2 		$671K Buy
+11,730
New +$680K 0.23% 84

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Rehmann Capital Advisory Group's CVS Position: Q1 2026 in Review

Rehmann Capital Advisory Group reduced its CVS Health (CVS) stake by 2% in Q1 2026, selling an estimated $11.5K and leaving 7,290 shares worth $524K. The position accounts for 0.03% of the portfolio, ranked #390.

Rehmann Capital Advisory Group first reported a position in CVS in Q2 2013 and has held it in 51 quarters since. The position peaked at $2.36M in Q1 2021. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Rehmann Capital Advisory Group held 7,290 shares of CVS Health worth $524K as of Q1 2026.
  • Rehmann Capital Advisory Group sold 149 CVS Health shares in Q1 2026, an estimated $11.5K.
  • CVS Health made up 0.03% of Rehmann Capital Advisory Group's portfolio in Q1 2026, its #390 holding.
  • Rehmann Capital Advisory Group first reported a position in CVS Health in Q2 2013 and has held it in 51 quarters since.
  • Rehmann Capital Advisory Group's CVS Health position peaked at $2.36M in Q1 2021.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Rehmann Capital Advisory Group's 13F filing for Q1 2026, filed 15 May 2026.